A Novel CRB2 Mutation Associated With FSGS and ESRD in an Adult Patient
Case Reports in Nephrology · 2026-01 · 2026 (1)
DOI: 10.1155/crin/8140153 ↗Kurz gefasst
Fachartikel in der Zeitschrift Case Reports in Nephrology, online erschienen am 20.05.2026. Verfasst von Michele Marchini und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, Azienda Sociosanitaria Ligure 5, La Spezia, 19121, Italy. Die Arbeit nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Department of Science and Technology of Jilin Province.
Abstract (Originalsprache)
Background
Chronic kidney disease (CKD) is a major global health concern, with a substantial proportion of cases that remain of undetermined cause. Mutations in genes affecting podocyte structure and function, are increasingly recognized as causes of focal segmental glomerulosclerosis (FSGS), a common but highly nonspecific histological pattern of kidney injury, that ultimately lead to CKD. Case Presentation We report the case of a 55‐year‐old male who presented with hypertension and end‐stage renal disease (ESRD) of unknown etiology. He had a progressive decline in kidney function and proteinuria beginning in young adulthood. A kidney biopsy showed a pattern of FSGS. A comprehensive workup did not identify autoimmune or inflammatory causes. Whole‐exome sequencing detected a previously undescribed heterozygous CRB2 mutation (c.1037G > T, p.Cys346Phe), predicted to be deleterious.
Discussion
Animal models of CRB2 deprivation in podocytes showed progression toward FSGS. In humans, CRB2 mutations have previously been linked to severe early‐onset nephrotic syndrome, typically in homozygous or compound heterozygous states. This is the first report of an adult‐onset CRB2‐associated FSGS in a heterozygous state, suggesting a milder disease course with a progressive kidney decline. As with other genetic forms of FSGS, we hypothesize that heterozygous CRB2 mutations may permit near‐normal renal function for years until cumulative stressors trigger podocyte injury and CKD progression.
Conclusion
This case expands the clinical spectrum of CRB2‐related kidney disease and highlights the importance of genetic testing in adults with unexplained CKD. Identifying genetic forms of CKD may refine diagnostic and therapeutic approaches in nephrology.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Nephrology, Azienda Sociosanitaria Ligure 5, La Spezia, 19121, Italy.
ORCID-Profile: Michele Marchini
Förderung
- Department of Science and Technology of Jilin Province
Zitieren
APA
Marchini, M., Mocka, S., & Trezzi, M. (2026). A Novel CRB2 Mutation Associated With FSGS and ESRD in an Adult Patient. Case Reports in Nephrology, 2026(1). https://doi.org/10.1155/crin/8140153
Vancouver
Marchini M, Mocka S, Trezzi M. A Novel CRB2 Mutation Associated With FSGS and ESRD in an Adult Patient. Case Reports in Nephrology. 2026;2026(1). doi:10.1155/crin/8140153
BibTeX
@article{Marchini2026,
author = {Marchini, Michele and Mocka, Sonila and Trezzi, Matteo},
title = {A Novel CRB2 Mutation Associated With FSGS and ESRD in an Adult Patient},
journal = {Case Reports in Nephrology},
year = {2026},
volume = {2026},
number = {1},
doi = {10.1155/crin/8140153}
}
EUVIMED